Helix BioPharma Corp. Closes $3.0 Million Private Placement
January 13, 2020 17:32 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco
January 08, 2020 10:57 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results
December 13, 2019 07:35 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer,...
Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study
December 11, 2019 18:09 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates...
Helix BioPharma Corp. Reports Voting Results
December 06, 2019 19:12 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results
October 25, 2019 07:33 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today...
Helix BioPharma Corp. Board Changes
October 10, 2019 17:05 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. and Moffit Cancer Centre to Present at World Molecular Imaging Congress
September 03, 2019 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Closes $7.0 Million Private Placement
August 21, 2019 17:05 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial
August 07, 2019 19:06 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...